| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 4 393-405, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
A Sgambato, Y Doki, I Schieren and IB Weinstein
Columbia-Presbyterian Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
Human tumors often display increased expression of cyclin E, suggesting that this might contribute to their abnormal growth. However, we reported recently that overexpression of a human cyclin E cDNA in the nontransformed mouse mammary epithelial cell line HC11 resulted in increased expression of the cell cycle-inhibitory protein p27Kip1 and inhibition of cell growth. To further address the role of cell context, in the present study we analyzed in parallel the effects of cyclin E overexpression in two fibroblast cell lines (Rat1 and NIH3T3) and three nontumorigenic mammary epithelial cell lines (the human cell lines 184B5 and MCF-10F and the mouse cell line HC11). This was associated with increased cyclin E-associated kinase activity in Rat1, NIH3T3, and MCF-10F cells but not in HC11 and 184B5 cells. The derivatives of the latter two cell lines showed increased expression of the p27Kip1 protein and inhibition of cell growth. There was a shortening of the G1 phase in the derivatives of the Rat1 and MCF-10F cells but not in the derivatives of the other three cell lines. Contrary to a previous hypothesis, overexpression of cyclin E was not able to confer anchorage-independent growth in any of these cell lines. However, overexpression of cyclin E was associated with increased resistance to transforming growth factor beta-mediated growth inhibition in the 184B5 and HC11 cells and a decrease in transforming growth factor beta stimulation of the Rat1 and NIH3T3 fibroblasts. Thus, overexpression of the same cyclin E cDNA has cell type-specific effects on various growth parameters. Therefore, additional studies are required to better understand the significance of the frequent increase of cyclin E expression in human tumors.
This article has been cited by other articles:
![]() |
H. Wingate, N. Zhang, M. J. McGarhen, I. Bedrosian, J. W. Harper, and K. Keyomarsi The Tumor-specific Hyperactive Forms of Cyclin E Are Resistant to Inhibition by p21 and p27 J. Biol. Chem., April 15, 2005; 280(15): 15148 - 15157. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Bhowmick, M. Ghiassi, M. Aakre, K. Brown, V. Singh, and H. L. Moses From the Cover: TGF-{beta}-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest PNAS, December 23, 2003; 100(26): 15548 - 15553. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sgambato, M. Migaldi, M. Montanari, A. Camerini, A. Brancaccio, G. Rossi, R. Cangiano, C. Losasso, G. Capelli, G. P. Trentini, et al. Dystroglycan Expression Is Frequently Reduced in Human Breast and Colon Cancers and Is Associated with Tumor Progression Am. J. Pathol., March 1, 2003; 162(3): 849 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Keyomarsi, S. L. Tucker, T. A. Buchholz, M. Callister, Y. Ding, G. N. Hortobagyi, I. Bedrosian, C. Knickerbocker, W. Toyofuku, M. Lowe, et al. Cyclin E and Survival in Patients with Breast Cancer N. Engl. J. Med., November 14, 2002; 347(20): 1566 - 1575. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. CLEMENT, A. HENRION-CAUDE, V. BESNARD, and S. CORROYER Role of Cyclins in Epithelial Response to Oxidants Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): S81 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.B. Weinstein Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis Carcinogenesis, May 1, 2000; 21(5): 857 - 864. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Harwell, D. C. Porter, C. Danes, and K. Keyomarsi Processing of Cyclin E Differs between Normal and Tumor Breast Cells Cancer Res., January 1, 2000; 60(2): 481 - 489. [Abstract] [Full Text] |
||||
![]() |
J. J. Del Pizzo, A. Borkowski, S. C. Jacobs, and N. Kyprianou Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient Survival Am. J. Pathol., October 1, 1999; 155(4): 1129 - 1136. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |